Corticosteroids in ARDS: An evidence-based review

Critical Care Clinics

Volumn 18, Issue 1, 2002, Pages 79-89

  Luce, John M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETAMETHASONE; CORTICOSTEROID; CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; METHYLPREDNISOLONE; PLACEBO;

ADRENAL INSUFFICIENCY; ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; HUMAN; HYDROCORTISONE RELEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK;

EID: 0036118334     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(03)00066-6     Document Type: Review

References (47)

1. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin
2. Effects of the combination of hydrocortisone (HC)-fludro-cortisone (FC) on mortality in septic shock
3. The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling
4. Acute respiratory distress in adults
5. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome: Diagnosis and treatment
6. Sepsis complicating the acute respiratory distress syndrome
7. The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination
8. High-dose corticosteroids in patients with the adult respiratory distress syndrome
9. Reversal of late septic shock with supraphysiologic doses of hydrocortisone
10. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
11. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock
12. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
13. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study
14. From mega to more reasonable doses of corticosteroids: A decade to recreate hope
15. Acute respiratory distress syndrome: Potential pharmacologic interventions
16. The effectiveness of hydrocortisone in the management of severe infections
17. Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
18. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A double-blind, placebo-controlled trial
19. Established ARDS treated with a sustained course of adrenocortical steroids
20. Clinical risks for development of the acute respiratory distress syndrome
21. Effectiveness of betamethasone in management of severe infections: A double-blind study
22. The acute respiratory distress syndrome
23. Corticosteroid therapy in severe illness
24. Steroid controversy in sepsis and septic shock: A meta-analysis
25. The cardiopulmonary response to massive doses of steroids in patients with septic shock
26. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock
27. Corticosteroids and antibiotics in adult respiratory distress syndrome: A review
28. Corticosteroids in septic shock: Resurrection of the last rites?
29. Thirty years of clinical trials in acute respiratory distress syndrome
30. Fibroproliferative phase of ARDS: Clinical findings and effects of corticosteroids
31. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: Patterns of response and predictors of outcome
32. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial
33. Glucocorticoid treatment of sepsis and acute respiratory distress syndrome: Time for a critical reappraisal
34. Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)
35. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
36. Clinical predictors of the adult respiratory distress syndrome
37. The adult respiratory distress syndrome: Clinical features, factors influencing prognosis and principles of management
38. Cortisol response to corticotropin and survival in septic shock
39. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors
40. Fat embolism prophylaxis with corticosteroids: A prospective study in high-risk patients
41. Steroids in the treatment of clinical septic shock
42. Adrenal insufficiency occurring during septic shock: Incidence, outcome, and relationship to peripheral cytokine levels
43. The effects of high-dose corticosteroids in patients with septic shock: A prospective, controlled study
44. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis
45. The acute respiratory distress syndrome
46. Early steroid therapy for respiratory failure
47. Methylprednisolone for unresolving ARDS